Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12619001251112
Ethics application status
Approved
Date submitted
4/09/2019
Date registered
11/09/2019
Date last updated
13/11/2019
Date data sharing statement initially provided
11/09/2019
Type of registration
Retrospectively registered

Titles & IDs
Public title
Attitudes towards sun protection and new technology in skin cancer prevention in healthy adults
Scientific title
Attitudes towards sun protection and new technology in skin cancer prevention in healthy adults - a qualitative study
Secondary ID [1] 298764 0
none
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
sunburn 313698 0
sun exposure 313699 0
skin cancer 313700 0
Condition category
Condition code
Public Health 312112 312112 0 0
Health promotion/education
Cancer 312113 312113 0 0
Malignant melanoma
Cancer 312114 312114 0 0
Non melanoma skin cancer
Injuries and Accidents 312115 312115 0 0
Burns

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
This is an exploratory qualitative study on patient attitudes towards use of sun protection and new technology in skin cancer prevention.

A series of focus groups will be conducted, with each participant to only attend one focus group. Participants will be asked to complete a demographic survey prior to attending the focus group. The facilitator will follow a semi-structured format and follow the discussion guide. Topics in the discussion guide include current sun protection practices, and participants will be introduced to new technologies to prevent skin cancer. These technologies assist with reminders for sunscreen application.

The assistant facilitator will audio record the focus group and takes notes. Each focus group will last 70 minutes and be held at the Institute of Health and Biomedical Innovation, Kelvin Grove, Brisbane.
Intervention code [1] 315026 0
Not applicable
Comparator / control treatment
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 320754 0
sun safety practices as assessed by thematic analysis of recorded focus group
Timepoint [1] 320754 0
One-off focus group
Secondary outcome [1] 372736 0
Nil
Timepoint [1] 372736 0
Nil

Eligibility
Key inclusion criteria
18 years of age or older, regularly use cosmetics, and are very fair to medium skin type (Fitzpatrick skin type I-III)
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
Nil

Study design
Purpose
Duration
Cross-sectional
Selection
Convenience sample
Timing
Both
Statistical methods / analysis
Content thematic analysis will be conducted. There will be an iterative process of reading, reviewing and refining themes and subthemes. Codes and theme development will be led entirely by the data.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
10/09/2019
Date of last participant enrolment
Anticipated
23/09/2019
Actual
23/09/2019
Date of last data collection
Anticipated
4/10/2019
Actual
23/09/2019
Sample size
Target
16
Accrual to date
Final
18
Recruitment in Australia
Recruitment state(s)
QLD

Funding & Sponsors
Funding source category [1] 303321 0
Commercial sector/Industry
Name [1] 303321 0
SunFly Brands Inc
Country [1] 303321 0
United States of America
Primary sponsor type
Commercial sector/Industry
Name
SunFly Brands Inc
Address
4306 3rd Ave. NW, Seattle, Washington, 98107, United States
Country
United States of America
Secondary sponsor category [1] 303343 0
None
Name [1] 303343 0
Address [1] 303343 0
Country [1] 303343 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 303855 0
Queensland University of Technology University Human Research Ethics Committee [EC00171]
Ethics committee address [1] 303855 0
Ethics committee country [1] 303855 0
Australia
Date submitted for ethics approval [1] 303855 0
12/08/2019
Approval date [1] 303855 0
09/09/2019
Ethics approval number [1] 303855 0
1900000765

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 95030 0
Dr Elke Hacker
Address 95030 0
Queensland University of Technology, Institute of Health and Biomedical Innovation (IHBI), 60 Musk Ave, Kelvin Grove, QLD, 4059
Country 95030 0
Australia
Phone 95030 0
+61 7 3138 9674
Fax 95030 0
Email 95030 0
[email protected]
Contact person for public queries
Name 95031 0
Elke Hacker
Address 95031 0
Queensland University of Technology, Institute of Health and Biomedical Innovation (IHBI), 60 Musk Ave, Kelvin Grove, QLD, 4059
Country 95031 0
Australia
Phone 95031 0
+61 7 3138 9674
Fax 95031 0
Email 95031 0
[email protected]
Contact person for scientific queries
Name 95032 0
Elke Hacker
Address 95032 0
Queensland University of Technology, Institute of Health and Biomedical Innovation (IHBI), 60 Musk Ave, Kelvin Grove, QLD, 4059
Country 95032 0
Australia
Phone 95032 0
+61 7 3138 9674
Fax 95032 0
Email 95032 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.